Combination of gemcitabine-containing magnetoliposome and oxaliplatin-containing magnetoliposome in breast cancer treatment: A possible mechanism with potential for clinical application.
about
P2860
Combination of gemcitabine-containing magnetoliposome and oxaliplatin-containing magnetoliposome in breast cancer treatment: A possible mechanism with potential for clinical application.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 27 May 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Combination of gemcitabine-con ...... tial for clinical application.
@en
Combination of gemcitabine-con ...... tial for clinical application.
@nl
type
label
Combination of gemcitabine-con ...... tial for clinical application.
@en
Combination of gemcitabine-con ...... tial for clinical application.
@nl
prefLabel
Combination of gemcitabine-con ...... tial for clinical application.
@en
Combination of gemcitabine-con ...... tial for clinical application.
@nl
P2093
P2860
P356
P1433
P1476
Combination of gemcitabine-con ...... tial for clinical application.
@en
P2093
Chengshou Zhang
Jiangyi Liu
Jiansong Tong
Wenjing Zhu
Wenman Lin
P2860
P304
43762-43778
P356
10.18632/ONCOTARGET.9671
P407
P577
2016-05-27T00:00:00Z